Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate Cancer

NCT00004929 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

BIOLOGICAL: MUC-2-KLH vaccine
BIOLOGICAL: QS21

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]